Comments on: Dermatomyositis and Kaposi sarcoma

References

1. 1.↵
   1. Alghanim KK,
   2. Gasmelseed BG.

   Kaposi’s sarcoma associated with adult dermatomyositis. Saudi Med J 2021; 42: 570–573.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Fan PT,
   2. Yu DT,
   3. Clements PJ,
   4. Fowlston S,
   5. Eisman J,
   6. Bluestone R.

   Effect of corticosteroids on the human immune response: comparison of one and three daily 1 gm intravenous pulses of methylprednisolone. J Lab Clin Med 1978; 91: 625.

   OpenUrlPubMedWeb of Science
3. 3.↵
   1. Dantzig PI.

   Kaposi Sarcoma and Polymyositis. Arch Dermatol 1974; 110: 605–607.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.
   1. Weiss VC,
   2. Serushan M.

   Kaposi’s sarcoma in a patient with dermatomyositis receiving immunosuppressive therapy. Arch Dermatol 1982; 118: 183–185.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.
   1. Almog Y,
   2. Ben-Yehuda A,
   3. Ben-Chetrit E.

   Dermatomyositis associated with the recurrence of transitional cell carcinomas and Kaposi’s sarcoma. Clinical and Experimental Rheumatology 1991; 9: 285–288.

   OpenUrlPubMedWeb of Science
6. 6.
   1. Simeoni, S.,
   2. Puccetti, A.,
   3. Moruzzi, S. et al.

   Dermatomyositis complicated with Kaposi sarcoma: a case report. Clin Rheumatol 2007; 26: 440–442.

   OpenUrlPubMed
7. 7.↵
   1. Liu Y,
   2. Jiang L.

   Cutaneous Kaposi’s sarcoma. BMJ 2021; 373: n926.

   OpenUrlFREE Full Text